Scarica l'app Stockscreener
185.91
0.08%
-0.14
Precedente Chiudi:
$186.05
Aprire:
$184.72
Volume 24 ore:
726.69K
Relative Volume:
0.61
Capitalizzazione di mercato:
$15.01B
Reddito:
$8.19B
Utile/perdita netta:
$758.19M
Rapporto P/E:
20.25
EPS:
9.18
Flusso di cassa netto:
$1.06B
1 W Prestazione:
-0.40%
1M Prestazione:
+6.23%
6M Prestazione:
+26.69%
1 anno Prestazione:
-37.31%
Intervallo 1D:
$180.47
$187.36
Intervallo di 1 settimana:
$180.47
$189.41
Portata 52W:
$125.10
$301.45
Icon Plc Stock (ICLR) Company Profile
Nome
Icon Plc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta ICLR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
185.91 | 14.47B | 8.19B | 758.19M | 1.06B | 9.18 |
|
TMO
Thermo Fisher Scientific Inc
|
525.83 | 198.09B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
206.15 | 146.89B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
636.91 | 50.67B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.04 | 39.19B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
204.76 | 34.64B | 15.70B | 1.24B | 2.01B | 6.9036 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-09 | Downgrade | Jefferies | Buy → Hold |
| 2025-09-03 | Aggiornamento | Rothschild & Co Redburn | Neutral → Buy |
| 2025-08-21 | Downgrade | Citigroup | Buy → Neutral |
| 2025-07-24 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-04-29 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-04-14 | Downgrade | TD Cowen | Buy → Hold |
| 2025-04-10 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-03-21 | Downgrade | Goldman | Buy → Neutral |
| 2025-01-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-10-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Iniziato | Redburn Atlantic | Neutral |
| 2024-09-18 | Iniziato | Leerink Partners | Outperform |
| 2024-06-06 | Iniziato | Goldman | Buy |
| 2023-12-15 | Iniziato | Truist | Buy |
| 2023-09-13 | Iniziato | TD Cowen | Outperform |
| 2023-01-17 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-01-13 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-11-09 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-09-07 | Iniziato | UBS | Buy |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-05-24 | Iniziato | Guggenheim | Buy |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2021-09-27 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-23 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-14 | Iniziato | Citigroup | Neutral |
| 2021-04-13 | Ripresa | BofA Securities | Neutral |
| 2021-04-01 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | Iniziato | Barclays | Equal Weight |
| 2021-03-01 | Aggiornamento | UBS | Neutral → Buy |
| 2021-02-26 | Aggiornamento | Truist | Hold → Buy |
| 2020-07-24 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-04-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-03-02 | Iniziato | Deutsche Bank | Hold |
| 2020-01-27 | Downgrade | SunTrust | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-09-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | Aggiornamento | UBS | Sell → Neutral |
| 2019-01-25 | Aggiornamento | Mizuho | Neutral → Buy |
| 2018-10-26 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-10-09 | Iniziato | UBS | Sell |
| 2018-04-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2018-02-15 | Reiterato | Mizuho | Neutral |
| 2018-01-19 | Iniziato | Evercore ISI | Outperform |
| 2017-10-27 | Reiterato | Barclays | Equal Weight |
| 2017-09-11 | Iniziato | BofA/Merrill | Buy |
| 2017-07-31 | Aggiornamento | SunTrust | Hold → Buy |
| 2017-07-27 | Reiterato | Mizuho | Neutral |
| 2017-06-29 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Icon Plc Borsa (ICLR) Ultime notizie
ICON Plc (ICLR) Stock Analysis: A Promising 17.90% Upside For Healthcare Investors - DirectorsTalk Interviews
Inspire Investing LLC Raises Holdings in Icon Plc $ICLR - MarketBeat
ICON plc (ICLR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
L. Roy Papp & Associates LLP Reduces Holdings in Icon Plc $ICLR - MarketBeat
Evercore Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $240 - 富途牛牛
ICON plc Experiences Valuation Adjustment Amidst Competitive Market Landscape - Markets Mojo
Running Oak Capital LLC Has $15.60 Million Holdings in Icon Plc $ICLR - MarketBeat
Sendero Wealth Management LLC Buys New Stake in Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Stock Position Increased by Marks Group Wealth Management Inc - MarketBeat
ICON plc Announces Third Quarter 2025 Earnings Call - MSN
AstraZeneca and Icon Plc Launch Eplontersen Safety Study for Pregnant and Lactating Individuals - TipRanks
What Analysts Are Saying About Icon Stock - Benzinga
ICON suspends COVID vaccine study after BARDA notice - MSN
Can ICON’s Rebound Sustain Momentum? - StocksToTrade
ICON plc Hits Day High with 7.67% Surge in Strong Intraday Performance - Markets Mojo
Real World Evidence Solutions Research and Forecast Report 2025-2030: Growth Opportunities in Emerging Markets and Increased Focus on End-To-End Rwe Services, & Personalized and Precision Medicine - GlobeNewswire Inc.
Is ICON plc’s Stock Soaring for the Right Reasons? - StocksToTrade
ICON plc Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
ICON plc (ICLR): Revolutionizing Clinical Trials with AI Innovations - MSN
ICON plc (ICLR) Stock Analysis: An Investor’s Guide to Understanding Its 31.67% Upside Potential - DirectorsTalk Interviews
ICON plc Schedules Third Quarter 2025 Earnings Conference Call - PharmiWeb.com
ICON plc Schedules Third Quarter 2025 Earnings Conference Call | User | sweetwaterreporter.com - FinancialContent
Canoe Financial LP Increases Position in Icon Plc $ICLR - MarketBeat
ICON Properties Plc (Malawi) | Interim Dividend Notice - AfricanFinancials
Farmers & Merchants Investments Inc. Purchases 2,181 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Sold by Swedbank AB - MarketBeat
Financiere des Professionnels Fonds d investissement inc. Purchases 11,894 Shares of Icon Plc $ICLR - MarketBeat
Goldman Sachs Group Inc. Sells 106,606 Shares of Icon Plc $ICLR - MarketBeat
Greenhaven Associates Inc. Takes Position in Icon Plc $ICLR - MarketBeat
LVM Capital Management Ltd. MI Sells 16,096 Shares of Icon Plc $ICLR - MarketBeat
U.S. Contract Research Organization Market Set for Dynamic Expansion as Key Players like IQVIA INC., ICON plc, Labcorp, Syneos Health - industrytoday.co.uk
Mizuho Securities Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $225 - 富途牛牛
Did ICON’s (ICLR) Internal CEO Succession Signal Strategic Continuity or Missed Opportunity for Change? - simplywall.st
Jefferies rates IQVIA, Charles River as Buy, ICON as Hold - MSN
Brokerages Set Icon Plc (NASDAQ:ICLR) PT at $219.64 - MarketBeat
Jefferies Downgrades ICON Public Limited (ICLR) to Hold From Buy - Insider Monkey
TD Cowen Maintains Icon PLC(ICLR.US) With Hold Rating, Cuts Target Price to $183 - 富途牛牛
Baird Financial Group Inc. Cuts Holdings in Icon Plc $ICLR - MarketBeat
Icon Plc Azioni (ICLR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):